-cog
A blood clotting factor, used in haemophilia.
- Drugs ending in -cog: 22
- Approved somewhere: 17
- With a US drug page: 0
- Stem
- -cog
- Class
- Blood clotting factors, used in bleeding disorders
- Sub-stems
- (-)eptacog, (-)nonacog, (-)octocog
Approved and clinical-stage drugs in ChEMBL whose names ending in -cog or one of its sub-stems, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Catridecacog | Approved | F13A1 | Coagulation factor XIII exogenous protein |
| Eptacog alfa (activated) | Approved | F7 | Coagulation factor VII exogenous protein |
| Eptacog beta (activated) | Approved | F7 | Coagulation factor VII exogenous protein |
| Nonacog beta pegol | Approved | F9 | Coagulation factor IX exogenous protein |
| Octocog alfa | Approved | F8 | Coagulation factor VIII exogenous protein |
| Vonicog alfa | Approved | VWF | von Willebrand factor exogenous protein |
| Eptacog alfa pegol (activated) | Phase 1 | F7 | Coagulation factor VII exogenous protein |
| Vatreptacog alfa (activated) | Phase 2 | — | — |
| Marzeptacog alfa (activated) | Phase 1 | — | — |
| Albutrepenonacog alfa | Approved | F9 | Coagulation factor IX exogenous protein |
| Eftrenonacog alfa | Approved | F9 | Coagulation factor IX exogenous protein |
| Trenonacog alfa | Phase 3 | F9 | Coagulation factor IX exogenous protein |
| Damoctocog alfa pegol | Approved | F8 | Coagulation factor VIII exogenous protein |
| Efanesoctocog alfa | Approved | F8 | Coagulation factor VIII exogenous protein |
| Efmoroctocog alfa | Approved | F8 | Coagulation factor VIII exogenous protein |
| Lonoctocog alfa | Approved | F8 | Coagulation factor VIII exogenous protein |
| Moroctocog alfa | Approved | F8 | Coagulation factor VIII exogenous protein |
| Simoctocog alfa | Approved | F8 | Coagulation factor VIII exogenous protein |
| Susoctocog alfa | Approved | F8 | Coagulation factor VIII exogenous protein |
| Turoctocog alfa | Approved | F8 | Coagulation factor VIII exogenous protein |
| Turoctocog alfa pegol | Approved | F8 | Coagulation factor VIII exogenous protein |
| Omfiloctocog alfa | Phase 3 | F8 | Coagulation factor VIII exogenous protein |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO